AAUDYOR but with $6m cash the market is valuing the underlying business at $12m when in a poor year still made $3m npat.I'm loading up
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025